NEW YORK--(BUSINESS WIRE)--American Oriental Bioengineering, Inc. (AMEX: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced GLP has received over $6.0 million in orders for its Jinji Series of products which are expected to be delivered during the fourth quarter.
